Supported by
The Industrial Fellowship Postdoc program objectives focus on the promotion of new preclinical imaging products and the offer of unique joint imaging services, particular focusing in nanomedicine research provided by BIOEMTECH as well as on the development of a commercial radiolabelling kit for nanoparticles supplied by NCSR D. Research activities carried out so far, cover the following areas: (i) The extensive evaluation of BIOEMTECH’S small animal imaging systems (γ-eye and β-eye) through imaging studies on normal and/or pathological small animal models (mice) administered with SPECT (99mTc-labelled) and PET (18F-/68Ga-labelled) radiopharmaceuticals respectively, for enhancing their performance on hardware and software level. (ii) The creation of a price list regarding imaging services to be provided by BIOEMTECH and the establishment of imaging workflows in accordance to similar activity centers. (iii) The radiolabelling of hybrid magnetic nanoparticles (MNPs) validated in the frame of ongoing H2020 projects run by BIOEMTECH and the standardization of a ligand-mediated labelling methodology for MNPs taking into account the expertise of NCSR “D”. The project is implemented according to the initial plan and all goals have been met. One small alteration in the sequence of activities has been made though. A highest priority was given to the evaluation of the β-eye system, since it became apparent that it was of a high marketing importance for the product to be finalized earlier than scheduled. Thus, β-eye was completed ahead of its deadline and the completion of the tomographic module of the γ-eye system was scheduled for the next semester.
